Search research articles
Contact Us
Filters
Showing results (431-440 of 475) with videos related to
Page
of 48
Sort By:
Journal of Pain and Symptom Management
|
January 8, 2017
Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning Conversations
Gabrielle B Rocque, J Nicholas Dionne-Odom, Chao-Hui Sylvia Huang, et al.
Nature Communications
|
July 15, 2020
Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins
Noura Alzahofi, Tobias Welz, Christopher L Robinson, et al.
CNS Drug Reviews
|
June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders
Lynne E Rueter, David J Anderson, Clark A Briggs, et al.
Diabetologia
|
May 22, 2013
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
H C Looker, S O Nyangoma, D T Cromie, et al.
European Journal of Medical Genetics
|
July 25, 2015
Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patients
Ana Beleza-Meireles, Rachel Hart, Jill Clayton-Smith, et al.
Physiological Genomics
|
February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population
Mohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 28, 2010
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107
John Malysz, David J Anderson, Jens H Grønlien, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 2005
Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists
Mahmood Ahmed, Michael A Briggs, Steven M Bromidge, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Page
of 48
Search research articles
Search
Showing results (431-440 of 475) with videos related to
Sort By:
Page
of 48
Journal of Pain and Symptom Management
|
January 8, 2017
Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning Conversations
Gabrielle B Rocque, J Nicholas Dionne-Odom, Chao-Hui Sylvia Huang, et al.
Nature Communications
|
July 15, 2020
Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins
Noura Alzahofi, Tobias Welz, Christopher L Robinson, et al.
CNS Drug Reviews
|
June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders
Lynne E Rueter, David J Anderson, Clark A Briggs, et al.
Diabetologia
|
May 22, 2013
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
H C Looker, S O Nyangoma, D T Cromie, et al.
European Journal of Medical Genetics
|
July 25, 2015
Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patients
Ana Beleza-Meireles, Rachel Hart, Jill Clayton-Smith, et al.
Physiological Genomics
|
February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population
Mohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S Bitner, William H Bunnelle, David J Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 28, 2010
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107
John Malysz, David J Anderson, Jens H Grønlien, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 7, 2005
Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists
Mahmood Ahmed, Michael A Briggs, Steven M Bromidge, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Page
of 48